Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland – the SAKK 95/16 prostate study. (2021). Swiss Medical Weekly, 151(0910), w20464. https://doi.org/10.4414/smw.2021.20464